CHI Advisors’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $52.3M | Sell |
3,014,199
-102,818
| -3% | -$1.78M | 20.72% | 1 |
|
|
2023
Q2 | $56.5M | Buy |
3,117,017
+115,182
| +4% | +$2.09M | 17.14% | 1 |
|
|
2023
Q1 | $79.8M | Sell |
3,001,835
-168,057
| -5% | -$4.47M | 21.2% | 2 |
|
|
2022
Q4 | $61.3M | Sell |
3,169,892
-239,866
| -7% | -$4.64M | 16.32% | 2 |
|
|
2022
Q3 | $71.2M | Buy |
3,409,758
+302,951
| +10% | +$6.33M | 19.15% | 2 |
|
|
2022
Q2 | $24.9M | Buy |
3,106,807
+449,350
| +17% | +$3.6M | 9.5% | 4 |
|
|
2022
Q1 | $18.6M | Buy |
2,657,457
+87,978
| +3% | +$617K | 7.92% | 4 |
|
|
2021
Q4 | $34.7M | Buy |
2,569,479
+84,755
| +3% | +$1.14M | 11.51% | 4 |
|
|
2021
Q3 | $41.9M | Buy |
2,484,724
+116,836
| +5% | +$1.97M | 12.24% | 4 |
|
|
2021
Q2 | $69M | Buy |
2,367,888
+43,093
| +2% | +$1.25M | 16.04% | 3 |
|
|
2021
Q1 | $91.4M | Sell |
2,324,795
-30,004
| -1% | -$1.18M | 18.3% | 2 |
|
|
2020
Q4 | $53.5M | Buy |
2,354,799
+2,508
| +0.1% | +$57K | 15.07% | 3 |
|
|
2020
Q3 | $53.3M | Buy |
2,352,291
+46,297
| +2% | +$1.05M | 18.95% | 2 |
|
|
2020
Q2 | $74.9M | Buy |
+2,305,994
| New | +$74.9M | 29.21% | 2 |
|